Skip to main content
Caplight Logo









APITBIO, Inc.

APITBIO, Inc.

Private
SeoulHealthcare & Life Scienceshttps://apitbio.com/

Last Round

Strategic

Dec 6, 2024

Total Funding Raised

$17.17M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

APITBIO, Inc. is a biotechnology company that develops antibody-based therapeutics for cancer and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

antibody therapeuticsmonoclonal antibodybispecific antibodydrug discoverybiotechoncologyCAR-Tantibody discoverybiologicssynthetic antibody librarydrug pipelineL1CAMCD171biopharmaout-licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

APITBIO, Inc. Comparables

Compare APITBIO, Inc. with similar companies based on industry and business-model similarity.

APITBIO, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Y-Biologics
80%
Phanes Therapeutics
79%
Aimed Bio Inc.
78%

APITBIO, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicDec 6, 2024
GrantApr 30, 2024
Series AFeb 8, 2021
SeedJul 1, 2019
AngelMar 1, 2019

APITBIO, Inc. Investors

Notable investors and investment history

APITBIO, Inc. investors
InvestorRounds
KDB Capital CorpSeries A
Shinhan Venture InvestmentSeries A, Seed
UTC InvestmentSeries A
Mirae Equity PartnersSeries A
KB SecuritiesSeries A
Hyundai Technology InvestmentSeries A
Kolon InvestmentSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 53% MoM.

  • May 19, 2026

    Monthly visitors increased 634% MoM, from 237 to 1.7K.

APITBIO, Inc. Filings

Explore SEC and related filing metadata, where available.

APITBIO, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about APITBIO, Inc.'s valuation, stock price, and market status.

Is APITBIO, Inc. a public or private company?

APITBIO, Inc. is a private company.

What is the current stock price of APITBIO, Inc.?

APITBIO, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is APITBIO, Inc. worth (valuation)?

Valuation information for APITBIO, Inc. is not publicly available.

Can I buy APITBIO, Inc. stock?

APITBIO, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was APITBIO, Inc.'s last funding round?

APITBIO, Inc.'s most recent funding round was Strategic on December 6, 2024.

Who are the main investors in APITBIO, Inc.?

Key investors in APITBIO, Inc. include KDB Capital Corp, Shinhan Venture Investment, UTC Investment, Mirae Equity Partners, KB Securities.

Will APITBIO, Inc. IPO soon?

No public IPO plans have been announced for APITBIO, Inc..

How can I track APITBIO, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor APITBIO, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Year Founded2018
Last FundingDec 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?